An Australian stem cell and regenerative medicine company

September 05, 2024

Investor Webinar

Today, Cynata's CEO and MD, Dr Kilian Kelly, alongside CBO Dr Mathias Kroll and Chair Dr Geoff Brooke, provided an update to investors, following the release of the FY 2024 Annual Report.